Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
22.99
-0.19 (-0.82%)
At close: Aug 13, 2026, 4:00 PM EDT
23.58
+0.59 (2.57%)
After-hours: Aug 13, 2026, 7:53 PM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $1.71 billion as of August 13, 2026. Its market cap has increased by 209.22% in one year.
Market Cap
1.71B
Enterprise Value
1.31B
1-Year Change
209.22%
Ranking
Category
Stock Price
$22.99
ChartMarket Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.71B, an increase of 596.57%. That is a compound annual growth rate of 16.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 1.71B | 56.35% |
| Dec 31, 2025 | 1.09B | -32.02% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.79B |
| Zymeworks | 1.77B |
| Syndax Pharmaceuticals | 1.77B |
| Recursion Pharmaceuticals | 1.76B |
| Fortrea Holdings | 1.74B |
| Ascentage Pharma Group International | 1.71B |
| Intellia Therapeutics | 1.69B |
| AnaptysBio | 1.69B |